Vontobel Holding
ABEO icon

Vontobel Holding’s Abeona Therapeutics ABEO Stock Holding History

Vontobel Holding’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,200
Closed -$90K – 1040
2021
Q3 		$90K Hold
3,200
– – ﹤0.01% 1107
2021
Q2 		$125K Hold
3,200
– – ﹤0.01% 1062
2021
Q1 		$150K Buy
+3,200
New +$176K ﹤0.01% 932

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vontobel Holding's ABEO Position: Q4 2021 in Review

Vontobel Holding sold out of Abeona Therapeutics (ABEO) in Q4 2021, closing a stake of 3,200 shares — an estimated $90K sold.

Vontobel Holding first reported a position in ABEO in Q1 2021 and held it in 3 quarters. The position peaked at $150K in Q1 2021. 52 funds tracked by Wall St. Rank hold ABEO as of Q4 2021.

  • Vontobel Holding reported no remaining Abeona Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Vontobel Holding sold 3,200 Abeona Therapeutics shares in Q4 2021, an estimated $90K.
  • Vontobel Holding first reported a position in Abeona Therapeutics in Q1 2021 and held it in 3 quarters.
  • Vontobel Holding's Abeona Therapeutics position peaked at $150K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q4 2021.

Based on Vontobel Holding's 13F filing for Q4 2021, filed 10 Feb 2022.